Dual Targeted Therapy with p53 siRNA and Epigallocatechingallate in a Triple Negative Breast Cancer Cell Model

Triple-negative breast cancer (TNBC) is a highly aggressive phenotype that is resistant to standard therapy. Thus, the development of alternative therapeutic strategies for TNBC is essential. The purpose of our in vitro study was to evaluate the impact of p53 gene silencing in conjunction with the a...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:PLoS One
Huvudupphovsmän: Braicu, Cornelia, Pileczki, Valentina, Pop, Laura, Petric, Roxana Cojocneanu, Chira, Sergiu, Pointiere, Eve, Achimas-Cadariu, Patriciu, Berindan-Neagoe, Ioana
Materialtyp: Artigo
Språk:Inglês
Publicerad: Public Library of Science 2015
Ämnen:
Research Article
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC4388814/
https://ncbi.nlm.nih.gov/pubmed/25849487
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0120936
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk